Brief Fact Summary. Hospital Corporation of America (HCA) (Defendant) appeals the decision of an administrative law judge ordering HCA (Defendant) to divest ownership of two hospitals acquired unlawfully.
Synopsis of Rule of Law. Section 7 of the Clayton Act is violated if an acquisition of a line of commerce lessens competition and creates a monopoly.
The jury may make a just and reasonable estimate of the damage based on relevant data, and render its verdict accordingly.View Full Point of Law
Issue. Is Section 7 of the Clayton Act violated if an acquisition of a line of commerce lessens competition and creates a monopoly?
Held. (Calvani, Commr.) Yes. Section 7 of the Clayton Act is violated if an acquisition of a line of commerce lessens competition and creates a monopoly. In order to analyze an alleged violation of the act, the commission must identify and examine the product market, the geographical area where competition could be harmed and the effect the acquisitions have on that line of commerce in that geographical area. The relevant product market, or line of commerce, is the provision of acute inpatient hospital services and emergency services provided to the critically ill. The FTC (Plaintiff) only examines the geographic market in relation to the area where competition could be harmed and, in this instance, the relevant market is that of the CUA, not the CMSA. There is no distinction between the hospitals owned by HCA (Defendant) and those managed by HCA (Defendant) because all of these hospitals have effectively been removed from the independent marketplace.
Clearly HCA's (Defendant) acquisition subjects the market to forces that are operating collusively and will likely harm competition in the relevant geographical area. However, the court must also evaluate the mitigating market factors, because without any barriers to entry, new firms could enter the market and balance the collusive forces of HCA (Defendant). The protracted and expensive process of obtaining a Certificate of Need (CON), and the ability of existing hospitals to forestall an increase in the number of hospitals in the geographical area, serves as a serious barrier to increase area competition. Also, with the flexibility of demand being low for hospital services, there is a high chance of price manipulation. Discrimination against different insurance groups, and therefore different consumer groups, is also highly possible. In terms of market collusion, it makes no difference whatsoever whether hospitals are for-profit or not-for-profit entities, given the fact that area hospitals have historically coordinated their services.
A violation of § 7 of the Clayton Act does not require that actual anticompetitive effects be demonstrated, but rather only that the violation is "incipient" or reasonably probable. The ALJ's decision is affirmed.
Discussion. The number of hospitals in any given geographical area is not solely determinate to the issue of competition. Observing the total number of hospital beds, the services provided, and the relative size of the health care corporations are also significant factors as they reflect any corporation's ability to control pricing per unit of service provided. The strategy to avoid sanctions by the FTC (Plaintiff) for corporations like HCA (Defendant) is to attempt to dilute either the market product classification by factoring in outpatient services and alternative sources of health care, or by expanding the relevant geographical area to shrink the appearance of their actual market control. In this case, HCA (Defendant) tried both of these tactics by arguing the need to include outpatient services and utilize the CMSA geographical area. Both attempts failed.